Literature DB >> 19901498

[Identification and validation of symptom clusters in patients with hepatocellular carcinoma].

Myung Sook Cho1, In Gak Kwon, Hee Sun Kim, Kyunghee Kim, Eunjung Ryu.   

Abstract

PURPOSE: The purpose of this study was to identify cancer-related symptom clusters and to validate the conceptual meanings of the revealed symptom clusters in patients with hepatocellular carcinoma.
METHODS: This study was a cross-sectional survey and methodological study. Patients with hepatocellular carcinoma (N=194) were recruited from a medical center in Seoul. The 20-item Symptom Checklist was used to assess patients' symptom severity. Selected symptoms were factored using principal-axis factoring with varimax rotation. To validate the revealed symptom clusters, the statistical differences were analyzed by status of patients' performance status, Child-Pugh classification, and mood state among symptom clusters.
RESULTS: Fatigue was the most prevalent symptom (97.4%), followed by lack of energy and stomach discomfort. Patients' symptom severity ratings fit a four-factor solution that explained 61.04% of the variance. These four factors were named pain-appetite cluster, fatigue cluster, itching-constipation cluster, and gastrointestinal cluster. The revealed symptom clusters were significantly different for patient performance status (ECOG-PSR), Child-Pugh class, anxiety, and depression.
CONCLUSION: Knowing these symptom clusters may help nurses to understand reasonable mechanisms for the aggregation of symptoms. Efficient symptom management of disease-related and treatment-related symptoms is critical in promoting physical and emotional status in patients with hepatocellular carcinoma.

Entities:  

Mesh:

Year:  2009        PMID: 19901498     DOI: 10.4040/jkan.2009.39.5.683

Source DB:  PubMed          Journal:  J Korean Acad Nurs        ISSN: 2005-3673            Impact factor:   0.984


  1 in total

1.  Effects of acupressure on fatigue and depression in hepatocellular carcinoma patients treated with transcatheter arterial chemoembolization: a quasi-experimental study.

Authors:  Su-Chen Lan; Yueh-E Lin; Shu-Ching Chen; Yu-Fang Lin; Yu-Jen Wang
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-23       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.